LabCorp price target lowered to $193 from $201 at Craig-Hallum. Craig-Hallum analyst Kevin lowered his price target for LabCorp to $193 from $201 after updating his estimates for the potential impact from Hurricane Florence and other items likely to affect the second half of 2018, such as the impact from the IT breach, PAMA, ASC 606 and the divestiture of the Covance Food Solutions business. While LabCorp has some cost levers it will likely pull and its free cash flow remains strong, he contends. The analyst reiterates a Buy rating on the shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.